Making 3TmpMRI More Accessible
By: Dan Sperling, MD I recently spoke with a Florida patient whose healthcare coverage is through a PPO. Two years ago, the urologist he sees through his PPO performed a TRUS biopsy two years ago that found two small areas of early stage cancer. He chose to go on Active Surveillance, and monitor using PSA. keep readingWe’ve Come A Long Way
By: Dan Sperling, MD I was a bit shocked when I came across an older research study titled “Two Consecutive Sets of Transrectal Ultrasound [TRUS] Guided Sextant Biopsies of the Prostate for the Detection of Prostate Cancer.”[i] I could hardly believe my eyes—two consecutive TRUS biopsies? The study is from 1998, and it gave me keep readingFocal Laser Ablation in Clinical Trials
By: Dan Sperling, MD Two well-respected clinical institutions, the National Cancer Institute (NCI), and the University of Chicago Medicine (UCM), have been conducting clinical trials on Focal Laser Ablation (FLA). They are considered interventional trials, meaning that a treatment is under investigation. Here is a little description of what each center is doing: a) NCI, under keep readingTelling the Truth about ED after Robotic Surgery
By: Dan Sperling, MD Over two years ago, I filed away an article from the New York Times that got my attention—but as my practice grew, I didn’t think about it. I recently ran across it, and in revisiting it I found I had to agree with the writer, Tara Parker-Pope.[i] (The writer is the keep readingLycopene and Prostate Cancer
“Let food be thy medicine and medicine be thy food.” So said Hippocrates, the ancient Greek physician whose famous oath for new doctors established important medical ethics. Wouldn’t it be great if diseases like prostate cancer could be cured—or altogether prevented—by eating the right foods?
keep reading
